FocusVirus-Associated Disease

Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention

See allHide authors and affiliations

Science Translational Medicine  02 Nov 2011:
Vol. 3, Issue 107, pp. 107fs7
DOI: 10.1126/scitranslmed.3002878

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.

View Full Text

Stay Connected to Science Translational Medicine